Will appreciate if you desist from these sorts of posts. Just not worth the energy and ultimately don’t reflect so well, not edifying.
Thankyou.
There is actually so much to be positive about, focusing on the fundamentals of a successfully formulated by Race , Bisantrene now, clinic ready & results ongoing show in synergy with the worlds leading oncology drugs.
The new IV formulation to be in given with leading global use oncology drugs in nearterm trials.
This should be the message being expressed to explain to readers about new strength and resurgence at last in RAC.
RAC - Charts & Price Action, page-19745
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |